
Hyperion Therapeutics is a privately held biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat disorders in the areas of orphan diseases and hepatology
4.13.12
Hyperion Therapeutics Files Registration Statement for Proposed Initial Public Offering
3.22.12
Hyperion Therapeutics Acquires Ravicti™ (glycerol phenylbutyrate) from Ucyclyd Pharma, Inc.